Plain-English translation of NCT06066853 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
This is an early-stage research study testing -assisted therapy as a potential treatment for fibromyalgia—a condition that causes widespread pain and other symptoms. The researchers want to see if this medication, combined with professional therapy support, can help reduce pain. They'll also use specialized brain imaging to understand how the treatment affects pain signals in the brain.
Current fibromyalgia treatments don't work well for everyone, and many people continue to suffer despite available options. Researchers believe this new treatment approach might offer relief by working on pain pathways in the brain in a different way than existing medications.
You likely qualify if…
You likely don't qualify if…
You would attend a screening visit where the research team checks your medical history, runs blood tests, and measures how your body responds to pressure. If you qualify, you would then participate in experimental sessions where you receive the medication along with therapy support. During these sessions, you'll also have your brain activity recorded using imaging scans (like an MRI) to help researchers understand how the treatment affects pain. Throughout the study, a support person you choose will stay with you during treatment evenings, and the team will remain in contact to make sure you're doing well.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
United States